The protein H1T2, a member of the histone H1 family, plays a crucial role in the chromatin structure and function within eukaryotic cells. Histones are highly alkaline proteins that package and order the DNA into structural units called nucleosomes, thereby playing a pivotal role in gene regulation, DNA replication, and repair processes. Specifically, H1T2 is involved in the condensation of chromatin to a more compact structure, influencing the accessibility of DNA to transcription factors and other DNA-binding proteins. This function is critical in the temporal regulation of gene expression, ensuring that specific genes are accessible at the appropriate times during cell cycle progression and development. The ability of H1T2 to modulate chromatin structure is thus fundamental to the proper execution of various cellular processes, including differentiation and the maintenance of genomic integrity.
The inhibition of H1T2 involves mechanisms that directly or indirectly affect its interaction with DNA and its capacity to facilitate chromatin compaction. One general mechanism of inhibition includes the post-translational modifications (PTMs) of H1T2, such as phosphorylation, methylation, and acetylation, which can alter its charge, conformation, and affinity for DNA, thereby modulating its function in chromatin organization. These PTMs act as regulatory signals that can recruit or repel specific chromatin-remodeling complexes or transcription machinery, influencing the chromatin's accessibility and the transcriptional status of genes. Another mechanism involves the competitive binding of other proteins or protein complexes to the DNA or histone itself, which can sterically hinder the association of H1T2 with chromatin, leading to alterations in chromatin structure and function. Additionally, changes in the cellular concentration of H1T2 through controlled expression or degradation can also serve as a means to regulate its activity and, consequently, chromatin dynamics. These inhibitory processes are essential for the fine-tuning of chromatin architecture and the responsive adaptation of gene expression profiles in accordance with cellular and environmental cues.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
YC-1 disrupts HIF-1α interaction with co-activators, hindering the transcriptional activity of HIF-1. | ||||||
PX-478 | 685898-44-6 | sc-507409 | 10 mg | $175.00 | ||
PX-478 can reduce HIF-1α levels by promoting its degradation. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2ME2 inhibits HIF-1α stabilization and HIF-1 transactivation. | ||||||
Quinomycin A | 512-64-1 | sc-202306 | 1 mg | $166.00 | 4 | |
A quinoxaline antibiotic that inhibits HIF-1 DNA binding activity. | ||||||
Topotecan | 123948-87-8 | sc-338718 | 100 mg | $582.00 | ||
Topotecan inhibits HIF-1α transcriptional activity by reducing its expression. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Disrupts the interaction between HIF-1α and p300, a co-activator, inhibiting HIF-1 transcriptional activity. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin inhibits HIF-1α synthesis at the translational level. | ||||||
Acriflavine | 8048-52-0 | sc-214489 sc-214489A | 25 g 100 g | $50.00 $171.00 | 2 | |
Acriflavine interferes with HIF-1 dimerization, thus inhibiting its activity. | ||||||
N,N′-(Dithiodi-2,1-ethanediyl)bis[2,5-dichloro-benzenesulfonamide | 927822-86-4 | sc-497219 | 25 mg | $330.00 | ||
Also called KC7F2, this compound decreases HIF-1α protein levels and its target gene expression. | ||||||
Hypoxia inducible factor-1α inhibitor | 934593-90-5 | sc-205346 sc-205346A sc-205346B sc-205346C | 1 mg 5 mg 10 mg 25 mg | $33.00 $114.00 $194.00 $411.00 | 40 | |
LW6 blocks HIF-1α accumulation and thus its downstream signaling. | ||||||